Literature DB >> 33440827

Morphological Changes and Prognostic Factors before and after Photodynamic Therapy for Central Serous Chorioretinopathy.

Yu Wakatsuki1, Koji Tanaka1, Ryusaburo Mori1, Koichi Furuya1, Akiyuki Kawamura1, Hiroyuki Nakashizuka1.   

Abstract

Central serous chorioretinopathy (CSC) is a disease of unknown etiology, but half-dose photodynamic therapy (hPDT) is well known to be effective for CSC. Infrared reflectance (IR) has been shown to be effective for detecting retinal pigmented epithelial and choroidal lesions, but no reports have focused on chorioretinal changes using IR images after as compared to before hPDT. This study aimed to clarify the features of IR images as well as retinal and choroidal morphological changes before and after treatment with verteporfin hPDT for CSC. We also examined prognostic factors associated with CSC treatment. This was a retrospective study that included 140 eyes of 140 patients (male/female ratio 122:18, mean age 53.4 ± 10.8 years) diagnosed with CSC who underwent hPDT in our hospital during the period from April 2015 to December 2018. We determined changes in visual acuity, therapeutic efficacy, central retinal thickness (CRT), central choroidal thickness (CCT), and IR images at one and three months after hPDT as compared to before treatment. Dry macula was defined as a complete resolution of serous retinal detachment after hPDT. History of smoking, disease duration, presence of drusen, presence of retinal pigment epithelium abnormalities, type of fluorescein angiographic leakage, and presence of choroidal vascular hyperpermeability were investigated as prognostic factors associated with treatment efficacy. CRT and CCT were measured using optical coherence tomography (Spectralis HRA-2; Heidelberg Engineering), and IR images after versus before treatment were compared using ImageJ software (version 1.52) to calculate the mean luminance for a 3 × 3 mm area in the macula. Compared with the values before treatment, CCT, CRT, and visual acuity showed significant improvements at one and three months after treatment, and the mean luminance of IR images was also significantly increased. Furthermore, the luminance on IR images tended to rise, though the values at one month and three months after treatment did not differ significantly. Disease duration was significantly associated with dry macula one month after treatment, and visual acuity and CRT before hPDT were both significantly related to dry macula three months after treatment. IR images tended to improve over time, from before treatment through one and three months after hPDT.

Entities:  

Keywords:  central serous chorioretinopathy; choroidal thickness; infrared reflectance; photodynamic therapy

Year:  2021        PMID: 33440827      PMCID: PMC7827861          DOI: 10.3390/ph14010053

Source DB:  PubMed          Journal:  Pharmaceuticals (Basel)        ISSN: 1424-8247


  32 in total

1.  Subfoveal choroidal thickness after treatment of central serous chorioretinopathy.

Authors:  Ichiro Maruko; Tomohiro Iida; Yukinori Sugano; Akira Ojima; Masashi Ogasawara; Richard F Spaide
Journal:  Ophthalmology       Date:  2010-05-15       Impact factor: 12.079

2.  High-resolution imaging of resolved central serous chorioretinopathy using adaptive optics scanning laser ophthalmoscopy.

Authors:  Sotaro Ooto; Masanori Hangai; Atsushi Sakamoto; Akitaka Tsujikawa; Kenji Yamashiro; Yumiko Ojima; Yoshihiko Yamada; Hideo Mukai; Susumu Oshima; Takashi Inoue; Nagahisa Yoshimura
Journal:  Ophthalmology       Date:  2010-07-29       Impact factor: 12.079

Review 3.  Central serous chorioretinopathy: update on pathophysiology and treatment.

Authors:  Benjamin Nicholson; Jason Noble; Farzin Forooghian; Catherine Meyerle
Journal:  Surv Ophthalmol       Date:  2013 Mar-Apr       Impact factor: 6.048

Review 4.  Central serous chorioretinopathy: An update on risk factors, pathophysiology and imaging modalities.

Authors:  Rebecca Kaye; Shruti Chandra; Jay Sheth; Camiel J F Boon; Sobha Sivaprasad; Andrew Lotery
Journal:  Prog Retin Eye Res       Date:  2020-05-11       Impact factor: 21.198

5.  Multimodal retinal imaging in central serous chorioretinopathy treated with oral eplerenone or photodynamic therapy.

Authors:  A Rabiolo; I Zucchiatti; A Marchese; G Baldin; R Sacconi; D Montorio; M V Cicinelli; L Querques; F Bandello; G Querques
Journal:  Eye (Lond)       Date:  2017-12-21       Impact factor: 3.775

6.  Central serous chorioretinopathy in younger and older adults.

Authors:  R F Spaide; L Campeas; A Haas; L A Yannuzzi; Y L Fisher; D R Guyer; J S Slakter; J A Sorenson; D A Orlock
Journal:  Ophthalmology       Date:  1996-12       Impact factor: 12.079

7.  Long-term follow-up of idiopathic central serous chorioretinopathy by fluorescein angiography.

Authors:  R Levine; A J Brucker; F Robinson
Journal:  Ophthalmology       Date:  1989-06       Impact factor: 12.079

8.  IDENTIFICATION OF POSTERIOR SEGMENT PATHOLOGY WITH EN FACE RETINAL IMAGING USING MULTICOLOR CONFOCAL SCANNING LASER OPHTHALMOSCOPY.

Authors:  Henry L Feng; Sumit Sharma; Sandra Stinnett; Sanjay Asrani; Prithvi Mruthyunjaya
Journal:  Retina       Date:  2019-05       Impact factor: 4.256

Review 9.  Non-resolving, recurrent and chronic central serous chorioretinopathy: available treatment options.

Authors:  Francesco Sartini; Michele Figus; Marco Nardi; Giamberto Casini; Chiara Posarelli
Journal:  Eye (Lond)       Date:  2019-03-01       Impact factor: 3.775

10.  Merging Information From Infrared and Autofluorescence Fundus Images for Monitoring of Chorioretinal Atrophic Lesions.

Authors:  Giovanni Ometto; Giovanni Montesano; Saman Sadeghi Afgeh; Georgios Lazaridis; Xiaoxuan Liu; Pearse A Keane; David P Crabb; Alastair K Denniston
Journal:  Transl Vis Sci Technol       Date:  2020-08-25       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.